Vivere Oncotherapies
Latest round
- Seed
Last raised
- Jan 2026
Total raised
- $10M
Investors
- 5
About Vivere Oncotherapies
Based in the US, Vivere Oncotherapies, Inc.Vivere Oncotherapies, Inc. specializes in advancing cancer treatment through immunotherapy.Vivere Oncotherapies specializes in the development of next-generation cancer therapies that aim to activate the immune system to target and eliminate cancer cells, particularly in cold tumors that evade detection by the body’s natural defenses. The company's core offerings center around a proprietary bioengineering platform that enhances the delivery and efficacy of treatments, enabling them to breach the immunological tolerance of tumors. This platform is underpinned by over 25 years of research and is designed to provide innovative solutions in oncology, addressing challenging cancers with few effective treatments available.Vivere Oncotherapies operates within a B2B model, engaging in partnerships with healthcare providers and research institutions to facilitate the development and deployment of its therapies. Revenue generation occurs through collaborative agreements and potential licensing deals, where partners may invest in the development process in exchange for access to the therapies and technology. The company may structure transactions based on milestones in research and development, leading to staged investments as specific therapeutic targets are achieved. Additionally, pricing structures may include upfront fees for access to the proprietary platform, milestone payments as progress is made, and royalties on future sales of therapies once they reach the market. As part of its growth strategy, the company aims to expand its presence in both North America and Europe, focusing on markets where advanced cancer therapies are in high demand. The strategic deployment of these funds is expected to support the introduction of new products designed to tackle challenging cancers, with specific timelines and detailed product launches to be outlined as development progresses.
Who invested in Vivere Oncotherapies
5 investors across 1 round
See all investors in Vivere Oncotherapies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 13, 2026
Amount
$10M
Investors
Questions about Vivere Oncotherapies
Who invested in Vivere Oncotherapies?
Vivere Oncotherapies has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vivere Oncotherapies raised?
Vivere Oncotherapies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vivere Oncotherapies last raise money?
Vivere Oncotherapies's most recent round on record is a Seed, in Jan 2026.
What does Vivere Oncotherapies do?
Based in the US, Vivere Oncotherapies, Inc.
Where is Vivere Oncotherapies headquartered?
Vivere Oncotherapies is headquartered in Berkeley, US.
Which VCs invest in companies like Vivere Oncotherapies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vivere Oncotherapies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Vivere Oncotherapies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.